Skip to main content

. 1987 Nov;46(11):875–876. doi: 10.1136/ard.46.11.875-b

Oral methotrexate in the treatment of rheumatoid arthritis: allergic agranulocytosis?

M Brumage, L Trümper, M Seitz

PMCID: PMC1003409 PMID: 3426294

875

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Gruber G. G., Callen J. P. Systemic complications of commonly used dermatologic drugs. Cutis. 1978 Jun;21(6):825–829. [PubMed] [Google Scholar]
MacKinnon S. K., Starkebaum G., Willkens R. F. Pancytopenia associated with low dose pulse methotrexate in the treatment of rheumatoid arthritis. Semin Arthritis Rheum. 1985 Nov;15(2):119–126. doi: 10.1016/0049-0172(85)90029-0. [DOI] [PubMed] [Google Scholar]
Pierik M. G. Acute bone marrow suppression following one day oral administration of methotrexate. R I Med J. 1974 Aug;57(8):332–333. [PubMed] [Google Scholar]
Roenigk H. H., Jr, Auerbach R., Maibach H. I., Weinstein G. D. Methotrexate guidelines--revised. J Am Acad Dermatol. 1982 Feb;6(2):145–155. doi: 10.1016/s0190-9622(82)80064-9. [DOI] [PubMed] [Google Scholar]
Weinstein G. D. Methotrexate. Ann Intern Med. 1977 Feb;86(2):199–204. doi: 10.7326/0003-4819-86-2-199. [DOI] [PubMed] [Google Scholar]
Woolley P. V., 3rd, Sacher R. A., Priego V. M., Schanfield M. S., Bonnem E. M. Methotrexate-induced immune haemolytic anaemia. Br J Haematol. 1983 Aug;54(4):543–552. doi: 10.1111/j.1365-2141.1983.tb02132.x. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES